
The results of a new study on Vitamin D and pregnancy outcome. Plus, Is foam the future of nonsurgical female sterilization? And: Choosing a GnRH dose for ovarian stimulation

The results of a new study on Vitamin D and pregnancy outcome. Plus, Is foam the future of nonsurgical female sterilization? And: Choosing a GnRH dose for ovarian stimulation


Employing a multidisciplinary approach to gain an understanding of these complex conditions and incorporating disciplines such as engineering, biomechanics, material and computer science, and the basic medical sciences will lead to advances in our field.

Experts present the two sides to this issue, basing their arguments on outcomes data and likelihood of success.

A commentary on ACOG Practice Bulletin Number 150: Early pregnancy loss by Editor-in-Chief Charles J Lockwood, MD, MHCM

A new study examines the risk:benefit of the Essure device. And, does anti-osteoporosis medication in the wake of a fragility fracture reduce the risk of a future fracture? Plus: What role do high maternal blood glucose levels play in her child's future cardiovascular health?

Should NSAIDs be first-line treatment for heavy menstrual bleeding?

It rarely signifies uterine cancer, according to this study.

A clinical decision tool serves as a framework for providers to counsel patients about mode of hysterectomy.

A study tabulates the direct and indirect costs.

Change in Pap smear recommendation has meant fewer occasions for testing for the STI, according to one study.

A study examines whether computer-assisted detection on mammography provides sufficient benefit for the cost. Plus: Do first-time pregnancy cesarean deliveries increase the preterm birth in subsequent pregnancies. And, is conventional wisdom surrounding pregnancy and cancer accurate?

Preoperative magnetic resonance imaging (MRI) may lead to more aggressive care for breast cancer, including contralateral prophylactic mastectomies, according to the results of a Canadian retrospective cohort study.

Experts weigh the evidence for casting a wider net with biochemical screening plus ultrasound.

Expand the practical, clinical use of effective monitoring of tumor biomarkers to improve care of women with breast cancer. Learn more by downloading and reading this supplement.


Ultrasound could replace the stethoscope in ob/gyn, says this doctor who trains practitioners in the developing world.

A jury decides if excessive oxycontin played a role in fetal distress.

Compared with single-incision surgery, surgery using mini-laparoscopic instruments is safe and is correlated with lower operative time and less postoperative pain.

Laparoscopic excision should remain the standard of care for endometriosis, although its success depends on the surgeon’s ability to excise all disease from all effected areas.

Reconsidering the role of the laser in surgical gynecologic practice in view of the radical technical innovations that have changed the tool in recent years.

Financial sustainability, intellectual property rights, and protection of the idea are all considerations for physician inventors who want to create new medical devices.

A look at the risk-benefit equation of power morcellation and age. Plus: Does exercise prior to pregnancy reduce pelvic pain in pregnancy? And, are hospitals doing enough to promote breastfeeding in new mothers?

The FDA looks at the benefit/risk profile of Essure. And, what place does MRI have in breast cancer treatment? Plus: A look at ovarian stimulating agents.

An Alabama woman went for an annual pelvic exam and underwent a Pap test. It showed a high-grade squamous intraepithelial neoplasia and the gynecologist could not rule out cancer. The patient then had a colposcopy, which revealed high-grade dysplasia with negative endocervical currettings. Each was identified as a form of pre-cancer.

A new study looks at whether or not the HPV vaccine increases miscarriage risk. And, is there a link between nocturnal enuresis and sleep apnea in postmenopause? Plus: The impact of the Mediterranean diet on breast cancer risk.

Gynecologic surgeons need validated tools to assess performance and guide their efforts to maintain and improve their skills. C-SATS provides a crowdsourcing solution.

Here's a better strategy to bring an idea for a medical device to fruition.

cfDNA screening should not be performed in the general obstetric population, according to this Opinion.

A look at the ramifications of the FDA safety communication on morcellation. Plus: Are the odds better for extremely preferm infants? And, how technology may improve LARC adherence.